Evidence map›Paper›PMID 39033045›Full record

ArticleHPB : the official journal of the International Hepato Pancreato Biliary Association2024

Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer.

Andy Tran, Richard Zheng, Fabian Johnston, Jin He, William R Burns, Christopher Shubert, Kelly Lafaro, Richard A Burkhart

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HPB : the official journal of the International Hepato Pancreato Biliary Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andy TranJohns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins University, Baltimore, MD, USA.
Richard ZhengDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins University, Baltimore, MD, USA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.
Fabian JohnstonSidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.
Jin HeDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins University, Baltimore, MD, USA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.
William R BurnsDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins University, Baltimore, MD, USA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.
Christopher ShubertDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins University, Baltimore, MD, USA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.
Kelly LafaroDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins University, Baltimore, MD, USA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.
Richard A BurkhartDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Johns Hopkins University, Baltimore, MD, USA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA. Electronic address: burkhart@jhmi.edu.

Funding

Personalized preclinical models in pancreas cancer: a tractable approach to precision medicineK08CA248710 · NCI · JOHNS HOPKINS UNIVERSITY · PI BURKHART, RICHARD ANDREW · 2020 to 2024
$1.3M
NCI NIH HHS K08 CA248710
6 · The paper itself

Abstract

backgroundMinimally invasive pancreatic surgery (MIPS), when selectively utilized, has been shown to hasten recovery with outcomes comparable to open approaches, but access may not be equitable. This study explored variation in utilization of MIPS for pancreatic cancer.

methodsThe National Cancer Database was queried to identify patients diagnosed with a primary pancreatic neoplasm from 2010 to 2020. Study participants had diagnoses of clinical or pathologic stage 1-3 disease and received curative-intent surgery. Multivariable analyses assessed the association between surgical approach and patient and disease factors.

resultsInclusion criteria identified 73,137 patients: 51,408 underwent open surgery and 21,729 received MIPS. In our multivariable analysis, Black race was associated with reduced odds of MIPS (AOR 0.88; p = 0.02), while older age (AOR 1.17; p = 0.01), later year of diagnosis (AOR 1.57; p < 0.001), and private insurance coverage (AOR 1.30; p = 0.05) were associated with increased odds. When patients with adenocarcinoma were analyzed in isolation, disparities in MIPS utilization persisted even when controlling for disease stage.

conclusionSociodemographic factors like age, race, and insurance coverage appear to vary in the utilization of MIPS technologies for the treatment of pancreatic malignancy. Addressing variation with robust mixed methods approaches in the future is proposed to incorporate prospective interventions with highly annotated outcomes for additional study.

Indexed as

PancreatectomyPancreatic NeoplasmsAgedAge FactorsDatabases, FactualFemaleHealthcare DisparitiesHumansMaleMiddle AgedMinimally Invasive Surgical ProceduresRetrospective StudiesSociodemographic FactorsUnited States

Identifiers

PMID39033045
PMCPMC11446651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.